Skip to main content

Aldeyra Therapeutics, Inc.

ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001341235

In the last 90 days, Aldeyra Therapeutics, Inc. insiders filed 3 open-market purchases and 0 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.

Holders of 5% or more of ALDX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aldeyra Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ALDX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Barclays PLC13G5.48%3.31M sharesNewNov 6, 20261 filingNov 6, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

26 Schedule 13D and 13G filings on Aldeyra Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ALDX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 12, 202610:51 AM ETAQR Capital Management LLCand 1 other13G/A1.11%672.6K shares−5.11 ppfrom 6.22%Below 5%Sep 30, 2026SEC
Nov 6, 20262:38 PM ETBarclays PLC13G5.48%3.31M sharesNewSep 30, 2026SEC
Aug 12, 202610:48 AM ETAQR Capital Management LLCand 1 other13G6.22%3.75M sharesNewJun 30, 2026SEC
Jul 27, 20264:25 PM ETBlackRock, Inc.13G/A1.70%1.05M shares–Below 5%Jun 30, 2026SEC
May 15, 20264:00 PM ETPerceptive Advisors LLCand 2 others13G/A0.00%0 shares−7.00 ppfrom 7.00%Below 5%Mar 31, 2026SEC
Mar 26, 20263:26 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Feb 17, 20264:00 PM ETPerceptive Advisors LLCand 2 others13G/A7.00%4.19M shares−1.70 ppfrom 8.70%Dec 31, 2025SEC
Nov 14, 20254:00 PM ETPerceptive Advisors LLCand 2 others13G/A8.70%5.22M shares+1.90 ppfrom 6.80%Sep 30, 2025SEC
Aug 14, 20254:21 PM ETPerceptive Advisors LLCand 2 others13G/A6.80%4.05M shares−1.40 ppfrom 8.20%Jun 30, 2025SEC
Apr 7, 20256:52 PM ETPerceptive Advisors LLCand 2 others13G/A8.20%4.88M shares–Apr 3, 2025SEC
Nov 14, 2024Perceptive Advisors LLC13G/AOld format–––SEC
Feb 14, 2024Perceptive Advisors LLC13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13GOld format–New–SEC
Jan 29, 20245:25 PM ETBlackRock Inc.13GOld format–––SEC
Oct 19, 2023Perceptive Advisors LLC13G/AOld format–––SEC
Oct 4, 2023Knoll Capital Management, LLC13GOld format–New–SEC
Feb 14, 2023Perceptive Advisors LLC13G/AOld format–––SEC
Feb 3, 2023State Street Corp13G/AOld format–––SEC
Jul 8, 20224:56 PM ETBlackRock Inc.13GOld format–––SEC
Feb 14, 2022Perceptive Advisors LLC13G/AOld format–––SEC
Feb 9, 2022State Street Corp13GOld format–New–SEC
Feb 4, 20224:12 PM ETBlackRock Inc.13GOld format–New–SEC
Jan 4, 2022Domain Partners VI, L.P.13G/AOld format–––SEC
Feb 16, 2021Perceptive Advisors LLC13G/AOld format–––SEC
Feb 16, 2021683 Capital Management, LLC13G/AOld format–––SEC
Feb 12, 2021Prosight Management, LP13G/AOld format–––SEC

Form 144: proposed insider sales

7 notices from officers, directors and other affiliates planning to sell Aldeyra Therapeutics, Inc. shares, newest first.

Form 144 notices for ALDX
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Aug 12, 20255:50 PM ETMachatha StephenOfficer22.1K$116.1KAug 12, 2025Morgan Stanley Smith Barney LLCSEC
Aug 12, 20246:07 PM ETGreenberg BruceOfficer10.8K$55.3KAug 12, 2024Morgan Stanley Smith Barney LLCSEC
Aug 12, 20245:45 PM ETMachatha StephenOfficer16.0K$81.8KAug 12, 2024Morgan Stanley Smith Barney LLCSEC
Mar 12, 20244:03 PM ETStephen G. MachathaOfficer11.5K$36.5KMar 12, 2024Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Mar 11, 20249:11 PM ETGreenberg BruceOfficer13.2K$47.8KMar 11, 2024Morgan Stanley Smith Barney LLCSEC
Mar 11, 20248:43 PM ETMachatha StephenOfficer18.2K$66.0KMar 11, 2024Morgan Stanley Smith Barney LLCSEC
Mar 11, 20247:12 PM ETBrady Todd COfficer183.2K$595.5KMar 11, 2024MORGAN STANLEY SMITH BARNEY LLC EXECUTIVE SERVICESSEC